Concepedia

Author

Ryan M. Reyes

The University of Texas Health Science Center at San AntonioORCID

Also Known As

Ryan M Reyes, Ryan M. Reyes, Ryan Michael Reyes, Ryan Reyes

50

Publications

217

Citations

8

H-Index

13

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioThe University of Texas at San AntonioMays Cancer Center at UT Health San AntonioThe University of Texas Health Science Center at HoustonMoffitt Cancer Center
RM

About

Ryan M. Reyes is an author at The University of Texas Health Science Center at San Antonio specializing in cancer cell biology, tumor biology, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

44

2

Cell Biology

1

1

44

3

Immunology

1

1

44

4

Cancer Cell Biology

1

1

44

5

Cell Signaling

1

1

44

Ryan M. Reyes

×

7

Publications

183

Citations

7

H-Index

YearCitations

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Deyi Zhang, Ryan M. Reyes, Erica Osta,

Cancer Medicine

2021

44

CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade

Justin Drerup, Yilun Deng, Sri Lakshmi Pandeswara,

Cancer Research

2020

33

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study

Niannian Ji, Neelam Mukherjee, Ryan M. Reyes,

Journal for ImmunoTherapy of Cancer

2021

28

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice

Myrna Garcia, Yilun Deng, Clare Murray,

Aging and Cancer

2022

28

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Ryan M. Reyes, Yilun Deng, Deyi Zhang,

Journal for ImmunoTherapy of Cancer

2021

22

γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

Niannian Ji, Neelam Mukherjee, Zhen‐Ju Shu,

Cancer Immunology Research

2021

18

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

Haiyan Bai, Álvaro Padrón, Yilun Deng,

Journal for ImmunoTherapy of Cancer

2023

10

Page 1